These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5708144)

  • 21. Mechanism of action of vitamin K: evidence for the conversion of a precursor protein to prothrombin in the rat.
    Shah DV; Suttie JW
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1653-7. PubMed ID: 5283959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of vitamin K deficiency, warfarin, and inhibitors of protein synthesis upon the plasma levels of vitamin K-dependent clotting factors in the chick.
    Walz DA; Kipfer RK; Olson RE
    J Nutr; 1975 Aug; 105(8):972-81. PubMed ID: 1142015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The regulatory action of vitamin K.
    Olson RE; Philipps G; Wang NT
    Adv Enzyme Regul; 1968; 6():213-25. PubMed ID: 5720336
    [No Abstract]   [Full Text] [Related]  

  • 24. [Vitamin K dependent blood clotting proteins (author's transl)].
    Kopeć M
    Postepy Biochem; 1980; 26(1):3-28. PubMed ID: 6994082
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of action of vitamin K and how it is affected by anticoagulants].
    Schade R; Janowski K
    Pharmazie; 1976; 31(9):585-9. PubMed ID: 798207
    [No Abstract]   [Full Text] [Related]  

  • 27. Vitamin K and warfarin. Metabolism, function and interaction.
    Woolf IL; Babior BM
    Am J Med; 1972 Sep; 53(3):261-7. PubMed ID: 5054720
    [No Abstract]   [Full Text] [Related]  

  • 28. The vitamin K dependent, in vitro production of prothrombin.
    Shah DV; Suttie JW
    Biochem Biophys Res Commun; 1974 Oct; 60(4):1397-402. PubMed ID: 4425352
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanism of action of vitamin K: demonstration of a liver precursor of prothrombin.
    Suttie JW
    Science; 1973 Jan; 179(4069):192-4. PubMed ID: 4682251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism for potentiation of warfarin by phenylbutazone. Inhibition of vitamin K-dependent carboxylation and prothrombin synthesis by phenylbutazone in preparations from rat liver.
    Kelly LJ; Bell RG
    Biochem Pharmacol; 1981 Sep; 30(17):2443-9. PubMed ID: 21043243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for competition between vitamin K-dependent clotting factors for intracellular processing by the vitamin K-dependent gamma-carboxylase.
    Stanton C; Ross P; Hutson S; Wallin R
    Thromb Res; 1995 Oct; 80(1):63-73. PubMed ID: 8578539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments in understanding the mechanism of vitamin K and vitamin K-antagonist drug action and the consequences of vitamin K action in blood coagulation.
    Jackson CM; Suttie JW
    Prog Hematol; 1977; 10():333-59. PubMed ID: 337364
    [No Abstract]   [Full Text] [Related]  

  • 33. Carboxylation, the completion step in prothrombin biosynthesis.
    Girardot JM; Delaney R; Johnson BC
    Biochem Biophys Res Commun; 1974 Aug; 59(4):1197-203. PubMed ID: 4412315
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the site of action of dicumarol on prothrombin biosynthesis.
    Pereira M; Couri D
    Biochim Biophys Acta; 1971 May; 237(2):348-55. PubMed ID: 4105894
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolism and properties of a liver precursor to prothrombin.
    Suttie JW
    Vitam Horm; 1974; 32():463-81. PubMed ID: 4617405
    [No Abstract]   [Full Text] [Related]  

  • 36. [Difficulties in the study of the kinetics of the generation of IIa and Xa in the monitoring of treatment with low molecular weight heparin].
    Droulle C; Potron G; Buffet E; Lafaurie M; Rémy MG
    J Mal Vasc; 1987; 12 Suppl B():74-7. PubMed ID: 2834497
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulation of blood coagulation factor levels in plasma.
    Karpatkin M; Karpatkin S
    Curr Top Hematol; 1985; 5():113-25. PubMed ID: 3882341
    [No Abstract]   [Full Text] [Related]  

  • 38. A new carboxylation reaction. The vitamin K-dependent incorporation of H-14-CO3- into prothrombin.
    Esmon CT; Sadowski JA; Suttie JW
    J Biol Chem; 1975 Jun; 250(12):4744-8. PubMed ID: 1141226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition by warfarin enantiomers of prothrombin synthesis, protein carboxylation, and the regeneration of vitamin K from vitamin K epoxide.
    Bell RG; Ren P
    Biochem Pharmacol; 1981 Jul; 30(14):1953-8. PubMed ID: 7271884
    [No Abstract]   [Full Text] [Related]  

  • 40. Ineffectiveness of phylloquinone epoxide as an inhibitor of prothrombin synthesis in the rat.
    Goodman SR; Houser RM; Olson RE
    Biochem Biophys Res Commun; 1974 Nov; 61(1):250-7. PubMed ID: 4441396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.